new_0222_0603|SNSE|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0603|SNSE|1|Sensei Biotherapeutics Inc Total Current Assets (Quarterly) (USD)|Sensei Biotherapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Sensei Biotherapeutics Inc Inventories (Quarterly) (USD)|Sensei Biotherapeutics Inc Net PP&E (Quarterly) (USD)|Sensei Biotherapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Sensei Biotherapeutics Inc Total Liabilities (Quarterly) (USD)|Sensei Biotherapeutics Inc Total Current Liabilities (Quarterly) (USD)|Sensei Biotherapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Sensei Biotherapeutics Inc Total Deposits (Quarterly) (USD)|Sensei Biotherapeutics Inc Book Value (Quarterly) (USD)|Sensei Biotherapeutics Inc Retained Earnings (Quarterly) (USD)|Sensei Biotherapeutics Inc Treasury Stock (Quarterly) (USD)|Sensei Biotherapeutics Inc EV to Revenues|Sensei Biotherapeutics Inc EV to Earnings|Sensei Biotherapeutics Inc EV to Free Cash Flow|Sensei Biotherapeutics Inc EV to Assets (Quarterly)|Sensei Biotherapeutics Inc PS Ratio|Sensei Biotherapeutics Inc PE Ratio|Sensei Biotherapeutics Inc Price to Book Value|Sensei Biotherapeutics Inc PEG Ratio|Sensei Biotherapeutics Inc Debt to Equity Ratio|Sensei Biotherapeutics Inc Dividend Yield|Sensei Biotherapeutics Inc Shareholder Yield (TTM)|Sensei Biotherapeutics Inc Percent of Shares Outstanding Short|Sensei Biotherapeutics Inc Total Receivables (Quarterly) (USD)|Sensei Biotherapeutics Inc Total Payables (Quarterly) (USD)|Sensei Biotherapeutics Inc Total Capital Stock (Quarterly) (USD)|Sensei Biotherapeutics Inc Return on Invested Capital|Sensei Biotherapeutics Inc Quality Ratio Score|Sensei Biotherapeutics Inc Momentum Score|Sensei Biotherapeutics Inc Beta (1Y)|Sensei Biotherapeutics Inc Sustainable Growth Rate (TTM)|Sensei Biotherapeutics Inc Institutional Investor Ownership Percentage|Sensei Biotherapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Sensei Biotherapeutics Inc Total Employees (Annual)|Sensei Biotherapeutics Inc EPS Diluted (Quarterly) (USD)|Sensei Biotherapeutics Inc SG&A Expense (Quarterly) (USD)|Sensei Biotherapeutics Inc Shares Outstanding|Sensei Biotherapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Sensei Biotherapeutics Inc Ordinary Shares Number (Quarterly)|Sensei Biotherapeutics Inc Payout Ratio|Sensei Biotherapeutics Inc Quick Ratio (Quarterly)|Sensei Biotherapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Sensei Biotherapeutics Inc Stock Buybacks (Quarterly) (USD)|Sensei Biotherapeutics Inc Effective Tax Rate (TTM)|Sensei Biotherapeutics Inc Return on Equity|Sensei Biotherapeutics Inc Net Income (TTM) (USD)|Sensei Biotherapeutics Inc Revenue (TTM) (USD)|Sensei Biotherapeutics Inc Dividend Per Share (Quarterly) (USD)|Sensei Biotherapeutics Inc Revenue (Quarterly) (USD)|Sensei Biotherapeutics Inc Gross Profit (Quarterly) (USD)|Sensei Biotherapeutics Inc Pre-Tax Income (Quarterly) (USD)|Sensei Biotherapeutics Inc Net Income (Quarterly) (USD)|Sensei Biotherapeutics Inc Net Interest Income (Quarterly) (USD)|Sensei Biotherapeutics Inc Price (USD)|Sensei Biotherapeutics Inc Total Return Price (USD)|Sensei Biotherapeutics Inc Enterprise Value (USD)|Sensei Biotherapeutics Inc 30-Day Average Daily Volume|Sensei Biotherapeutics Inc 1 Year Price Returns (Daily)|Sensei Biotherapeutics Inc Short Interest|Sensei Biotherapeutics Inc PE Ratio (Forward)|Sensei Biotherapeutics Inc PE Ratio (Forward 1y)|Sensei Biotherapeutics Inc PS Ratio (Forward)|Sensei Biotherapeutics Inc PS Ratio (Forward 1y)|Sensei Biotherapeutics Inc Quarterly EPS Estimates (USD)|Sensei Biotherapeutics Inc Quarterly Revenue Estimates (USD)|Sensei Biotherapeutics Inc Quarterly EPS Surprise|Sensei Biotherapeutics Inc Quarterly Revenue Surprise|Sensei Biotherapeutics Inc Quarterly Actual EPS (USD)|Sensei Biotherapeutics Inc Quarterly Actual Revenue (USD)|Sensei Biotherapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Sensei Biotherapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Sensei Biotherapeutics Inc Price Target (USD)|Sensei Biotherapeutics Inc Consensus Recommendation|Sensei Biotherapeutics Inc Price Target Num Estimates|Sensei Biotherapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Sensei Biotherapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Sensei Biotherapeutics Inc Research and Development Expense (Quarterly) (USD)|Sensei Biotherapeutics Inc Reconciled Depreciation (Quarterly) (USD)|Sensei Biotherapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|Sensei Biotherapeutics Inc Land and Improvements (Quarterly) (USD)|Sensei Biotherapeutics Inc Buildings and Improvements (Quarterly) (USD)|Sensei Biotherapeutics Inc Other Properties (Quarterly) (USD)|Sensei Biotherapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0603|SNSE|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0603|SNSE|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0603|SNSE|5|127.8|127.8||127.8||127.8|127.8|127.8||127.8|127.8||||1.44106463878||||1.44|||1.44106463878||15.347826087||183|127.8||||||30.6363636364|91.2857142857|92|91.2857142857|91.2857142857|27.4||127.8|||91.2857142857|91.3333333333|||91.25|||||91.2857142857|91.2857142857|91.2857142857|1.44106463878|1.44106463878|1.44106463878|1.44017094017|1.4|15.347826087|||||91.25|91.25|91||91|91|29.0769230769|23.1818181818|11.5714285714|12.72|11.5714285714|18|14.1666666667|91.2857142857|91.2857142857|91.2857142857|||127.8|127.8||
new_0222_0603|SNSE|6|5|5||5||5|5|5||5|5||||263||||225|||263||23||2|5||||||11|7|1|7|7|10||5|||7|6|||4|||||7|7|7|263|263|263|234|10|23|||||8|8|3||3|3|13|11|14|25|14|21|18|7|7|7|||5|5||
new_0222_0603|SNSE|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0603|SNSE|201912|0.502|0.251||0.268||69.879|21.714|48.165||-68.662|-92.312|||||||||||||||3.547||||||||12.3166||-0.6216|0.982|||29.5583|||-0.39|||||||||-6.705|-6.705|-1.396||||||||||||||||||||||||2.425|0.023|1.396|||0.641|0.014||
new_0222_0603|SNSE|202003||||||||||||||||||||||||||||||||||12.3166||-0.3894|1.908||||||-0.4654|||||||||-4.692|-4.692|-1.629||||||||||||||||||||||||2.195|0.023|1.629||||||
new_0222_0603|SNSE|202006||||||||||||||||||||||||||||||||||12.3166||-0.3987|1.311||||||-0.3387|||||||||-4.91|-4.91|-0.003||||||||||||||||||||||||2.858|0.052|0.003||||||
new_0222_0603|SNSE|202009|4.429|3.733||1.05||57.196|4.715|52.481||-51.681|-107.281|||||||||||||||0.974||||||||12.3166|25|-0.4358|1.788|||29.5583|||-0.4358||||-21.674|||||-5.367|-5.367|-0.003||||||||||||||||||||||||3.576|0.064|0.003|||1.537|0.039||
new_0222_0603|SNSE|202012|20.076|16.596||1.266||77.871|4.83|73.041||-56.443|-112.412||||-25.8411|||||||||1.3327||3.882|||||||24.62|29.5583|32|-0.1736|2.521|30.5885||29.5583|||-0.1736||||-20.1|||||-5.131|-5.131|-0.054|16.5|16.5|488.6812|||407640|||||-2.96||-316.5541||-12.33|||||||-1||2.556|0.07|0.054|||1.767|0.094||
new_0222_0603|SNSE|202103|172.785|169.418||1.655||3.224|2.475|0.749||171.252|-120.384||||-11.6518||||2.5953|||||1.8685|||0.003||||||43.5154|18.9049||-0.42|4.604|30.5885||30.5885|||-0.42|-140.594|||-23.38|||||-7.972|-7.972|-0.003|14.53|14.53|275.5999|208264.2||571532|||||-0.325||-29.2308||-0.42||||29.5|1.25|4|-1.3014|-1.4601|3.365|0.098|0.003|||2.227|0.121|13.24|12.43
new_0222_0603|SNSE|202106|165.613|162.498||2.111||4.599|3.923|0.676||163.125|-130.155||||-4.9593||||1.8302|||||0.7226|||0.003||||||36.5783|30.5885||-0.32|3.886|30.5885||30.5885|||-0.3191||||-28.241|||||-9.771|-9.771|0.041|9.76|9.76|136.6128|175800.3333||221038|||||-0.2904||-10.189||-0.32||||24.3893|1.6|4|-1.4004|-1.3939|5.898|0.122|0.147|||2.47|0.385|7.89|10.78
new_0222_0603|SNSE|202109|158.162|156.662||3.06||6.041|5.264|0.777||155.208|-139.84||||-6.1436||||2.0733|||||1.7192|||0.003||||||41.6871|30.5885||-0.32|3.873|30.5885||30.5885|||-0.3385||||-32.559|||||-9.685|-9.685|0.064|10.52|10.52|165.129|173620.1||525867|||||-0.245||-30.6122||-0.32|||||2.6667||-1.3233|-1.57|6.443|0.136|0.214|||3.387|0.475|8.69|6.88
new_0222_0603|SNSE|202112|||||||||||||||-0.7738||||1.1434|||||1.094|||||||||42.6356||||||||||||||||||||||5.8|5.8|20.7994|111706.7|-79.3675|334716|||||-0.34|||||||||2.6667||-1.3233|||||||||4.82|4.11
new_0222_0603|SNSE|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.34|||||||||||||||||||||
new_0222_0603|SNSE|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.34|||||||||||||||||||||
new_0222_0603|SNSE|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.34|||||||||||||||||||||
new_0222_0603|SNSE|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.37|||||||||||||||||||||